Companies view Sunshine differently

Share this article:
Pfizer
Pfizer

A report by PMLive indicates that pharmaceutical companies have distinct views on what the Sunshine Act requires.

According to a presentation made at the International Society for Medical Publications Professionals, PMLive noted, for example, that Pfizer and AstraZeneca report payments for medical writing. The companies said they report the payments because the publications represent value for the company and author.

Shire's publications director Antonia Panayi, though, said her company does not consider these publications reportable because the value is limited to pharma, as opposed to being beneficial for professionals.

Panayi said the value is limited to “what has already been paid as part of their contractual agreement for the trial,” and that author “kudos” for publication would be difficult to quantify.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Penn and Teller give take on vaccines

The Las Vegas twosome give the anti-vaccination movement their signature treatment.

GSK allegations build in Jordan and Lebanon

GlaxoSmithKline says it is investigating allegations of employee misconduct. The company said in a statement that the allegations have numbers "very similar to those reported by other companies in our sector."

Generic Celebrex is coming

Pfizer and Teva's settlement puts generic Celebrex on the market by December.